$TRXC on NYSE AMERICAN
March 05, 2021
Asensus Surgical Announces Finalization of Name and Ticker Symbol Change
March 04, 2021
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
March 03, 2021
Asensus Surgical Announces FDA Clearance in General Surgery
March 01, 2021
Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference
February 23, 2021
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery
February 18, 2021
TransEnterix Announces New Training Center in EU
February 10, 2021
TransEnterix to Host Virtual Investor Day on February 23, 2021
February 01, 2021
TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
January 26, 2021
TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million
January 26, 2021
TransEnterix Announces $25.0 Million Bought Deal Offering of Common Stock
January 19, 2021
TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery
January 14, 2021
TransEnterix Announces Closing of $31.25 Million Registered Direct Offering of Common Stock
January 12, 2021
TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock
January 06, 2021
TransEnterix Provides Preliminary 2020 Year-End Corporate Update
January 04, 2021
TransEnterix to Participate in Two Upcoming Virtual Healthcare Conferences
December 17, 2020
TransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic Program
December 16, 2020
TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation
November 05, 2020
TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020
November 03, 2020
TransEnterix to Present at the Stifel 2020 Virtual Healthcare Conference
October 26, 2020
TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020
October 13, 2020
TransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical System
October 07, 2020
TransEnterix Announces Toshima Hospital in Japan to Initiate a Senhance® Digital Laparoscopy Program
September 23, 2020
TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
September 14, 2020
TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System
September 08, 2020
TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference
August 25, 2020
TransEnterix Announces New Employment Inducement Grant
August 13, 2020
TransEnterix Announces Appointment of Shameze Rampertab as Chief Financial Officer
August 05, 2020
TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2020
August 04, 2020
TransEnterix Announces Submission of General Surgery Expansion in the US
July 27, 2020
TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System
July 22, 2020
TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020
July 06, 2020
TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option
July 01, 2020
TransEnterix Announces Pricing of $13.0 Million Underwritten Public Offering of Common Stock
June 30, 2020
TransEnterix Announces Launch of Underwritten Public Offering of Common Stock
June 23, 2020
TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System
May 21, 2020
TransEnterix Announces Sinai Health System in Chicago to Initiate Program with the Senhance Surgical System
May 14, 2020
TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2020
May 05, 2020
TransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2020
March 16, 2020
TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2019
March 13, 2020
TransEnterix Receives FDA Clearance for First Machine Vision System in Robotic Surgery
March 09, 2020
TransEnterix Schedules Fourth Quarter and Fiscal Year 2019 Financial and Operating Results Conference Call for March 16, 2020
March 06, 2020
TransEnterix Announces Pricing of $15 Million Underwritten Public Offering
March 05, 2020
TransEnterix Announces Launch of Underwritten Public Offering
March 02, 2020
TransEnterix Announces St. Marianna University School of Medicine Toyoko Hospital in Japan to Initiate a Senhance Digital Laparoscopy Program
February 28, 2020
TransEnterix Announces Kitakyushu General Hospital Completes First Surgical Procedures with the Senhance Surgical System
February 12, 2020
TransEnterix Announces CE Mark Approval for Pediatric Indication for Senhance Surgical System
February 10, 2020
TransEnterix Announces Common Stock Purchase Agreement by Lincoln Park Capital Fund, LLC
January 29, 2020
TransEnterix Announces Kitakyushu General Hospital in Japan to Initiate a Senhance Digital Laparoscopy Program
January 21, 2020
TransEnterix Announces Klinikum Esslingen to Initiate a Senhance Surgical System Program
January 14, 2020
TransEnterix Announces Submission of 510(k) to FDA for First Machine Vision System in Robotic Surgery
- No Recent Filings Found.
